Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patientsYasuhiro Nakamura, N. Yamazaki, Haruki Doi et al.|Annals of Oncology|2020Cited by 140
Immune checkpoint inhibitor‐induced vitiligo in advanced melanoma could be related to increased levels of CCL19Taku Fujimura, Setsuya Aiba, Kenji Yoshino et al.|British Journal of Dermatology|2019Cited by 14